Mounjaro®
Starting from £179.99/mo
Start journey Learn moreVomiting is one of the most commonly reported side effects of Wegovy, and it typically peaks in the first few weeks of treatment or after a dose increase. In the STEP 1 trial, published in the New England Journal of Medicine, around one in four participants on semaglutide 2.4mg reported vomiting — most cases were mild to moderate and settled over time. That context matters: feeling sick after starting or stepping up your dose does not mean treatment is failing or that you should stop without speaking to a prescriber first. Wegovy is a prescription-only medicine that slows how quickly the stomach empties, which directly drives nausea and vomiting, particularly early on. Understanding what is normal, what to watch for, and when to get medical help can make a real difference to how you get through the adjustment period.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide activates GLP-1 receptors in both the gut and the brain. One result is that gastric emptying slows considerably, food and liquid leave the stomach more gradually than usual. That mechanism is partly responsible for the appetite reduction that makes Wegovy effective for weight management, but it is also the direct driver of nausea and vomiting, particularly when the body is first adapting to the medicine or adjusting to a higher dose.
The STEP 1 trial gives the clearest picture of how often this happens. Roughly a quarter of participants on 2.4mg semaglutide reported vomiting over the 68-week study period, compared with around 6% in the placebo group. Most events were graded mild or moderate. Fewer than 5% of participants stopped treatment because of gastrointestinal side effects overall. That is the realistic range to hold in mind: common, but rarely severe enough to end treatment.
Vomiting tends to cluster in two windows, the first few weeks after the very first injection, and the week or two following each upward dose step. Once your body has calibrated to a given dose, the frequency and intensity usually fall. Many people on Wegovy report that by the time they reach their maintenance dose, they have almost no gastrointestinal symptoms at all. Almost. Some people do find certain foods consistently trigger it, greasy, very rich or high-volume meals are the most frequent culprits.
For a broader overview of the full side-effect profile, the Wegovy side effects guide covers what to expect at each stage of treatment.
There is no single fix, but several practical adjustments consistently help. Eating smaller portions is probably the most effective single change, the stomach empties slowly on Wegovy, so overloading it is reliably uncomfortable. Eating slowly, stopping before you feel full, and avoiding lying down in the hour after a meal all reduce the likelihood of food coming back up.
Injection timing is worth considering. Some people find injecting in the evening means the peak of any nausea happens overnight when they are asleep. There is no clinical evidence that one time of day is universally better, but it is worth discussing with your prescriber if morning nausea is disruptive.
Hydration matters significantly. When vomiting does occur, sipping cool water steadily is more effective than drinking large amounts at once. Ginger-based drinks and dry, plain foods (crackers, plain rice, toast) help some people during acute episodes. Alcohol and fizzy drinks tend to worsen GI symptoms on semaglutide.
If vomiting is making your weekly dose difficult to tolerate, do not adjust your dose yourself. Your prescriber can consider staying at the current dose for longer before stepping up, which the NHS England weight management injections guidance notes as a reasonable approach to managing tolerability. For targeted advice on reducing episodes, see how to stop vomiting on Wegovy.
Most vomiting on Wegovy is unpleasant but not dangerous. There are situations, though, where you need to act quickly.
Get medical help promptly if you experience severe or persistent stomach pain that spreads to your back, with or without vomiting. This combination can indicate acute pancreatitis, which the MHRA flagged in its January 2026 Drug Safety Update as an infrequent but serious risk with GLP-1 medicines. It is rare, but it requires urgent assessment and should not be waited out at home.
Vomiting that continues for more than 24 hours, or that is so frequent you cannot keep fluids down, raises the risk of dehydration and electrolyte imbalance. Signs to watch for include dizziness on standing, significantly reduced urination, dry mouth and confusion. These warrant the same response: contact your GP, call NHS 111, or go to A&E if symptoms are severe.
If you vomit shortly after your weekly injection, the guidance is not to repeat the dose that week. The medicine is absorbed subcutaneously, so injecting into the tissue under the skin means vomiting does not affect how much semaglutide you have received. Wait until your next scheduled injection day. If you are uncertain, your prescriber or the patient information leaflet is the right place to check.
You can report any suspected side effect (including vomiting that concerns you) through the MHRA's Yellow Card scheme. Reports from patients are reviewed and help keep the safety data on Wegovy current. If something feels wrong, report it and speak to a clinician. If you want to discuss symptoms with our team, the contact page has details for our prescriber aftercare line, available seven days a week.
Some people on Wegovy notice that what they vomit changes depending on when it happens. Early in the day, or when the stomach is empty, vomiting often produces yellow or green bile rather than food. This is not a sign that something has gone wrong with the medicine. It simply means there is nothing else in the stomach to bring up. It can feel alarming the first time it happens. Mostly it is not. Staying hydrated and eating small amounts at regular intervals reduces how often it occurs.
If vomiting of bile is frequent, persistent, or accompanied by pain, that warrants a conversation with your prescriber, it can occasionally signal gallbladder involvement, which GLP-1 medicines carry a small elevated risk of. The Wegovy and bile vomiting page covers this pattern specifically, including when to flag it.
For a fuller picture of how nausea and vomiting interact throughout a course of treatment, the nausea and vomiting guide walks through the whole arc from first dose to maintenance. And if you are wondering whether what you are experiencing is typical, the semaglutide vomiting page sets out the clinical picture across the semaglutide class.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.